Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04683939 |
| Title | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BioNTech SE |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| START | San Antonio | Texas | 78229 | United States | Details | |
| University of Montreal - Centre Hospitalier de l´Université de Montréal | Montréal | H2X3E4 | Canada | Details | ||
| St. Michaels Hospital | Toronto | M5B1W8 | Canada | Details | ||
| Princess Margaret Cancer Centre - University Health Network | Toronto | M5G1X5 | Canada | Details |